{"id":"https://openalex.org/W1978154072","doi":"https://doi.org/10.1089/adt.2007.103","title":"An Automated Liquid Chromatography-Mass Spectrometry Process to Determine Metabolic Stability Half-Life and Intrinsic Clearance of Drug Candidates by Substrate Depletion","display_name":"An Automated Liquid Chromatography-Mass Spectrometry Process to Determine Metabolic Stability Half-Life and Intrinsic Clearance of Drug Candidates by Substrate Depletion","publication_year":2008,"publication_date":"2008-02-01","ids":{"openalex":"https://openalex.org/W1978154072","doi":"https://doi.org/10.1089/adt.2007.103","mag":"1978154072","pmid":"https://pubmed.ncbi.nlm.nih.gov/18336089"},"language":"en","primary_location":{"id":"doi:10.1089/adt.2007.103","doi":"https://doi.org/10.1089/adt.2007.103","is_oa":false,"landing_page_url":"https://doi.org/10.1089/adt.2007.103","pdf_url":null,"source":{"id":"https://openalex.org/S76283439","display_name":"Assay and Drug Development Technologies","issn_l":"1540-658X","issn":["1540-658X","1557-8127"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ASSAY and Drug Development Technologies","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5077899342","display_name":"Colleen A. McNaney","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Colleen A. McNaney","raw_affiliation_strings":["Pharmaceutical Candidate Optimization \u2013 Discovery Analytical Sciences, Bristol-Myers Squibb Company, Wallingford, CT","Pharmaceutical Candidate Optimization - Discovery Analytical Sciences, Bristol-Myers Squibb Company, Wallingford, CT 06492, USA. colleen.mcnaney@bms.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Candidate Optimization \u2013 Discovery Analytical Sciences, Bristol-Myers Squibb Company, Wallingford, CT","institution_ids":["https://openalex.org/I4210091812"]},{"raw_affiliation_string":"Pharmaceutical Candidate Optimization - Discovery Analytical Sciences, Bristol-Myers Squibb Company, Wallingford, CT 06492, USA. colleen.mcnaney@bms.com","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039501181","display_name":"Dieter M. Drexler","orcid":"https://orcid.org/0000-0003-2877-7973","observed_orcids":["https://orcid.org/0000-0003-2877-7973"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dieter M. Drexler","raw_affiliation_strings":["Pharmaceutical Candidate Optimization \u2013 Discovery Analytical Sciences, Bristol-Myers Squibb Company, Wallingford, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Candidate Optimization \u2013 Discovery Analytical Sciences, Bristol-Myers Squibb Company, Wallingford, CT","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013540666","display_name":"Serhiy Y. Hnatyshyn","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Serhiy Y. Hnatyshyn","raw_affiliation_strings":["Pharmaceutical Candidate Optimization \u2013 Discovery Analytical Sciences, Bristol-Myers Squibb Company, Princeton, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Candidate Optimization \u2013 Discovery Analytical Sciences, Bristol-Myers Squibb Company, Princeton, NJ","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041653454","display_name":"Tatyana A. Zvyaga","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tatyana A. Zvyaga","raw_affiliation_strings":["Applied Biotechnologies \u2013 Molecular Biosciences \u2013 Lead Discovery and Profiling, Bristol-Myers Squibb Company, Wallingford, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Applied Biotechnologies \u2013 Molecular Biosciences \u2013 Lead Discovery and Profiling, Bristol-Myers Squibb Company, Wallingford, CT","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016216031","display_name":"Jay O. Knipe","orcid":"https://orcid.org/0000-0002-2481-9235","observed_orcids":["https://orcid.org/0000-0002-2481-9235"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jay O. Knipe","raw_affiliation_strings":["Pharmaceutical Candidate Optimization \u2013 Metabolism and Pharmcokinetics \u2013 Discovery Support, Bristol-Myers Squibb Company, Wallingford, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Candidate Optimization \u2013 Metabolism and Pharmcokinetics \u2013 Discovery Support, Bristol-Myers Squibb Company, Wallingford, CT","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039122189","display_name":"James V. Belcastro","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James V. Belcastro","raw_affiliation_strings":["Applied Biotechnologies \u2013 Molecular Biosciences \u2013 Lead Discovery and Profiling, Bristol-Myers Squibb Company, Wallingford, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Applied Biotechnologies \u2013 Molecular Biosciences \u2013 Lead Discovery and Profiling, Bristol-Myers Squibb Company, Wallingford, CT","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"last","author":{"id":null,"display_name":"Mark Sanders","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark Sanders","raw_affiliation_strings":["Pharmaceutical Candidate Optimization \u2013 Discovery Analytical Sciences, Bristol-Myers Squibb Company, Princeton, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Candidate Optimization \u2013 Discovery Analytical Sciences, Bristol-Myers Squibb Company, Princeton, NJ","institution_ids":["https://openalex.org/I4210091812"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210091812"],"apc_list":null,"apc_paid":null,"fwci":1.6656,"has_fulltext":false,"cited_by_count":146,"citation_normalized_percentile":{"value":0.80232408,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"6","issue":"1","first_page":"121","last_page":"129"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.0024999999441206455,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10836","display_name":"Metabolomics and Mass Spectrometry Studies","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metabolic-stability","display_name":"metabolic stability","score":0.7720000147819519},{"id":"https://openalex.org/keywords/drug-candidates","display_name":"drug candidates","score":0.6710000038146973},{"id":"https://openalex.org/keywords/intrinsic-clearance","display_name":"intrinsic clearance","score":0.7400000095367432},{"id":"https://openalex.org/keywords/half-life","display_name":"half-life","score":0.7649999856948853},{"id":"https://openalex.org/keywords/substrate-depletion","display_name":"substrate depletion","score":0.9200000166893005},{"id":"https://openalex.org/keywords/liver-microsomes","display_name":"liver microsomes","score":0.9620000123977661},{"id":"https://openalex.org/keywords/robotic-liquid-handling","display_name":"robotic liquid handling","score":0.8159999847412109},{"id":"https://openalex.org/keywords/ion-trap-mass-spectrometry","display_name":"ion trap mass spectrometry","score":0.9269999861717224},{"id":"https://openalex.org/keywords/first-order-kinetics","display_name":"first-order kinetics","score":0.765999972820282}],"concepts":[{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.6945489645004272},{"id":"https://openalex.org/C162356407","wikidata":"https://www.wikidata.org/wiki/Q180809","display_name":"Mass spectrometry","level":2,"score":0.680200457572937},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6589614152908325},{"id":"https://openalex.org/C89311334","wikidata":"https://www.wikidata.org/wiki/Q1124842","display_name":"Drug metabolism","level":3,"score":0.5493074655532837},{"id":"https://openalex.org/C2777289219","wikidata":"https://www.wikidata.org/wiki/Q7632154","display_name":"Substrate (aquarium)","level":2,"score":0.542667806148529},{"id":"https://openalex.org/C64489805","wikidata":"https://www.wikidata.org/wiki/Q873864","display_name":"Liquid chromatography\u2013mass spectrometry","level":3,"score":0.5107460021972656},{"id":"https://openalex.org/C113196181","wikidata":"https://www.wikidata.org/wiki/Q485223","display_name":"Analytical Chemistry (journal)","level":2,"score":0.3712421655654907},{"id":"https://openalex.org/C62231903","wikidata":"https://www.wikidata.org/wiki/Q1057","display_name":"Metabolism","level":2,"score":0.29729342460632324},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.17918765544891357},{"id":"https://openalex.org/C127313418","wikidata":"https://www.wikidata.org/wiki/Q1069","display_name":"Geology","level":0,"score":0.0},{"id":"https://openalex.org/C111368507","wikidata":"https://www.wikidata.org/wiki/Q43518","display_name":"Oceanography","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001330","descriptor_name":"Electronic Data Processing","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001331","descriptor_name":"Automation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002851","descriptor_name":"Chromatography, High Pressure Liquid","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003627","descriptor_name":"Data Interpretation, Statistical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004364","descriptor_name":"Pharmaceutical Preparations","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D006207","descriptor_name":"Half-Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007202","descriptor_name":"Indicators and Reagents","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008862","descriptor_name":"Microsomes, Liver","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D010599","descriptor_name":"Pharmacokinetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012984","descriptor_name":"Software","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012997","descriptor_name":"Solvents","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013056","descriptor_name":"Spectrophotometry, Ultraviolet","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013058","descriptor_name":"Mass Spectrometry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1089/adt.2007.103","doi":"https://doi.org/10.1089/adt.2007.103","is_oa":false,"landing_page_url":"https://doi.org/10.1089/adt.2007.103","pdf_url":null,"source":{"id":"https://openalex.org/S76283439","display_name":"Assay and Drug Development Technologies","issn_l":"1540-658X","issn":["1540-658X","1557-8127"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ASSAY and Drug Development Technologies","raw_type":"journal-article"},{"id":"pmid:18336089","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18336089","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Assay and drug development technologies","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.4000000059604645,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":26,"referenced_works":["https://openalex.org/W152943885","https://openalex.org/W1125033069","https://openalex.org/W1862868295","https://openalex.org/W1899693663","https://openalex.org/W1966880707","https://openalex.org/W1970559437","https://openalex.org/W1981505214","https://openalex.org/W1986025090","https://openalex.org/W2009894278","https://openalex.org/W2022463947","https://openalex.org/W2022867019","https://openalex.org/W2033276002","https://openalex.org/W2033784113","https://openalex.org/W2058557855","https://openalex.org/W2064799851","https://openalex.org/W2102968881","https://openalex.org/W2109128239","https://openalex.org/W2113747457","https://openalex.org/W2116796907","https://openalex.org/W2131515230","https://openalex.org/W2144465276","https://openalex.org/W2236622920","https://openalex.org/W2356379002","https://openalex.org/W2473807700","https://openalex.org/W4285719527","https://openalex.org/W4406065843"],"related_works":["https://openalex.org/W1981505214","https://openalex.org/W2464374827","https://openalex.org/W2501416232","https://openalex.org/W2095502157","https://openalex.org/W2055175185","https://openalex.org/W4392367568","https://openalex.org/W2067514904","https://openalex.org/W2001342472","https://openalex.org/W2123301394","https://openalex.org/W4200360358"],"abstract_inverted_index":{"An":[0],"automated":[1],"process":[2],"is":[3,79,85,98,157,175,195],"described":[4],"for":[5,87,102,161],"the":[6,10,44,61,136,158,162,170,176,190,196,199],"detailed":[7],"assessment":[8],"of":[9,16,21,63,77,105,132,138,167,169,181,183,198],"in":[11,19],"vitro":[12],"metabolic":[13,133],"stability":[14,134],"properties":[15],"drug":[17,152],"candidates":[18],"support":[20],"pharmaceutical":[22],"property":[23],"profiling.":[24],"Compounds":[25],"are":[26,37,47,145,207],"incubated":[27],"with":[28],"liver":[29],"microsomes":[30,116],"using":[31],"a":[32,184],"robotic":[33],"liquid":[34,51],"handler.":[35],"Aliquots":[36],"taken":[38],"at":[39,189],"various":[40],"time":[41,110,159],"points,":[42,111],"and":[43,92,115,141,149,186,201],"resulting":[45],"samples":[46],"quantitatively":[48],"analyzed":[49],"by":[50],"chromatography-mass":[52],"spectrometry":[53],"utilizing":[54],"ion":[55],"trap":[56],"mass":[57],"spectrometers":[58],"to":[59,107,147],"determine":[60],"amount":[62],"compound":[64,185],"remaining.":[65],"From":[66],"these":[67],"data":[68,90,202],"metabolism":[69,182],"rates":[70],"can":[71],"be":[72],"calculated.":[73],"A":[74],"high":[75],"degree":[76],"automation":[78],"achieved":[80],"through":[81,135],"custom":[82],"software,":[83],"which":[84,144],"employed":[86],"instrument":[88],"setup,":[89],"processing,":[91],"results":[93],"reporting.":[94],"The":[95,122],"assay":[96,204],"setup":[97,197],"highly":[99],"configurable,":[100],"allowing":[101],"any":[103],"combination":[104],"up":[106],"six":[108],"user-selected":[109],"variable":[112],"substrate":[113,127],"concentration,":[114],"or":[117],"other":[118],"biologically":[119],"active":[120],"media.":[121],"data,":[123],"based":[124],"on":[125],"relative":[126],"depletion,":[128],"affords":[129],"an":[130],"estimate":[131],"calculation":[137],"half-life":[139],"(t(1/2))":[140],"intrinsic":[142],"clearance,":[143],"used":[146],"differentiate":[148],"rank":[150],"order":[151],"leads.":[153],"In":[154],"general,":[155],"t(1/2)":[156],"necessary":[160],"metabolism,":[163],"following":[164],"first-order":[165],"kinetics,":[166],"50%":[168],"initial":[171],"compound.":[172],"Intrinsic":[173],"clearance":[174],"proportionality":[177],"constant":[178],"between":[179],"rate":[180],"its":[187],"concentration":[188],"enzyme":[191],"site.":[192],"Described":[193],"here":[194],"assay,":[200],"from":[203],"test":[205],"compounds":[206],"presented.":[208]},"counts_by_year":[{"year":2026,"cited_by_count":17},{"year":2025,"cited_by_count":26},{"year":2024,"cited_by_count":15},{"year":2023,"cited_by_count":18},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":12},{"year":2019,"cited_by_count":9},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":10},{"year":2015,"cited_by_count":7},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}